Kodiak Sciences Inc.
For the period ended Dec 31, 2024. Filed Mar 27, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Mar 27, 2025
KOD$108.06+0.9%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Operations and Comprehensive Loss
| Year Ended December 31, | |||
|---|---|---|---|
| 2024 | 2023 | 2022 | |
| Operating expenses | |||
| Research and development | $126,095 | $206,298 | $267,591 |
| General and administrative | 60,754 | 71,023 | 73,788 |
| Total operating expenses | 186,849 | 277,321 | 341,379 |
| Loss from operations | (186,849) | (277,321) | (341,379) |
| Interest income | 11,148 | 16,733 | 7,071 |
| Interest expense | — | (13) | (18) |
| Other income (expense), net | (506) | 110 | 503 |
| Net loss | $(176,207) | $(260,491) | $(333,823) |
| Net loss per common share, basic and diluted | $(3.35) | $(4.97) | $(6.39) |
| Weighted-average shares of common stock outstanding used in computing net loss per common share, basic and diluted | 52,583,148 | 52,414,256 | 52,249,620 |
| Other comprehensive income (loss) | |||
| Change in unrealized gains (losses) related to available-for-sale debt securities, net of tax | — | 1,307 | (1,307) |
| Total other comprehensive income (loss) | — | 1,307 | (1,307) |
| Comprehensive loss | $(176,207) | $(259,184) | $(335,130) |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.